NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States

ML Prasad, M Vyas, MJ Horne, RK Virk, R Morotti… - Cancer, 2016 - Wiley Online Library
BACKGROUND An increase in thyroid cancers, predominantly papillary thyroid carcinoma
(PTC), has been recently reported in children. METHODS The histopathology of 28 …

RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas

B Pekova, V Sykorova, S Dvorakova, E Vaclavikova… - Thyroid, 2020 - liebertpub.com
Background: Pediatric papillary thyroid carcinoma (PTC) is a rare malignancy, but with
increasing incidence. Pediatric PTCs have distinct clinical and pathological features and …

[HTML][HTML] NTRK and RET fusion–directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake

YA Lee, H Lee, SW Im, YS Song, DY Oh… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Molecular characterization in pediatric papillary thyroid cancer (PTC),
distinct from adult PTC, is important for developing molecularly targeted therapies for …

[HTML][HTML] NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis

B Pekova, V Sykorova, K Mastnikova, E Vaclavikova… - Cancers, 2021 - mdpi.com
Simple Summary NTRK fusion genes are important but not well studied molecular markers
in thyroid cancer. Their identification could help improve diagnosis and prognosis, and …

ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population

AU Bastos, AC de Jesus… - European journal of …, 2018 - academic.oup.com
Objective PTC-specific analysis identified novel fusions involving RET, BRAF, NTRK1,
NTRK3, AGK and ALK genes in adults and pediatric PTCs. Although many novel fusions are …

Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers

AT Franco, JC Ricarte-Filho, A Isaza… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE In 2014, data from a comprehensive multiplatform analysis of 496 adult papillary
thyroid cancer samples reported by The Cancer Genome Atlas project suggested that …

NTRK fusions identified in pediatric tumors: the frequency, fusion partners, and clinical outcome

X Zhao, C Kotch, E Fox, LF Surrey… - JCO precision …, 2021 - ascopubs.org
PURPOSE Neurotrophic tyrosine receptor kinase (NTRK) fusions have been described as
oncogenic drivers in a variety of tumors. However, little is known about the overall frequency …

Fusion oncogenes are the main genetic events found in sporadic papillary thyroid carcinomas from children

MICV Cordioli, L Moraes, AU Bastos, P Besson… - Thyroid, 2017 - liebertpub.com
Background: Previous studies reported significant differences in the clinical presentation
and outcomes of papillary thyroid carcinoma (PTC) in pediatric patients compared with …

Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma

TJ Musholt, PB Musholt, N Khaladj, D Schulz… - Surgery, 2000 - Elsevier
Background. The expression of RET/PTC chimeras was demonstrated in 10% to 20% of
sporadic papillary thyroid carcinomas (PTCs), whereas rearrangements ofNTRK 1 were …

RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.

I Bongarzone, P Vigneri, L Mariani, P Collini… - Clinical cancer research …, 1998 - AACR
The papillary carcinoma family (PCF) of thyroid tumors includes a wide variety of neoplastic
entities regarded as well-differentiated, poorly differentiated, and undifferentiated papillary …